Deutsch English Français

Contact

EP1280897

European procedure

Quick help

Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...

News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...

Extract from the Register of European Patents

EP About this file: EP1280897

EP1280897 - REGULATION OF NF-AT INTERACTING PROTEIN NIP 45 VARIANT [Right-click to bookmark this link]
Status	No opposition filed within time limit Status updated on 27.07.2007 Database last updated on 25.09.2024
Most recent event Tooltip	11.09.2009	Lapse of the patent in a contracting state New state(s): TR	published on 14.10.2009 [2009/42]
Applicant(s)	For all designated states Bayer HealthCare AG 51368 Leverkusen / DE
	[2006/38]
Former [2004/01]	For all designated states Bayer HealthCare AG 51368 Leverkusen / DE
Former [2003/06]	For all designated states Bayer Aktiengesellschaft 51368 Leverkusen / DE
Inventor(s)	01 / ENCINAS, Jeffrey 3-17-15, Ayameike-kita Nara, Nara 631-0032 / JP
	[2003/06]
Application number, filing date	01927920.7	25.04.2001
	[2003/06]
	WO2001EP04635
Priority number, date	US20000199356P	25.04.2000 Original published format: US 199356 P
	[2003/06]
Filing language	EN
Procedural language	EN
Publication	Type:	A2 Application without search report
	No.:	WO0181574
	Date:	01.11.2001
	Language:	EN
	[2001/44]
	Type:	A2 Application without search report
	No.:	EP1280897
	Date:	05.02.2003
	Language:	EN
	The application published by WIPO in one of the EPO official languages on 01.11.2001 takes the place of the publication of the European patent application.
	[2003/06]
	Type:	B1 Patent specification
	No.:	EP1280897
	Date:	20.09.2006
	Language:	EN
	[2006/38]
Search report(s)	International search report - published on:	EP	18.04.2002
Classification	IPC:	C12N15/12, C12N15/62, C12N5/10, C07K14/47, C12Q1/68, G01N33/50, G01N33/68, A61K38/17, A61K31/7105, A61K31/713, A61P11/06	[2003/06]
	CPC:	C07K14/4702 (EP); A61P11/06 (EP); A61P29/00 (EP); A61P31/00 (EP); A61P37/02 (EP); A61P37/08 (EP); (+) A61P43/00 (EP); C07K2319/00 (EP) (-)
Designated contracting states	AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LI, LU, MC, NL, PT, SE, TR [2003/06]
Extension states	AL	Not yet paid
	LT	Not yet paid
	LV	Not yet paid
	MK	Not yet paid
	RO	Not yet paid
	SI	Not yet paid
Title	German:	REGULATION EINER NF-AT INTERAGIERENDEN PROTEINVARIANTE NIP 45	[2003/06]
	English:	REGULATION OF NF-AT INTERACTING PROTEIN NIP 45 VARIANT	[2003/06]
	French:	REGULATION DE VARIANTE DE PROTEINE NIP 45 A INTERACTION AVEC NF-AT	[2003/06]
Entry into regional phase	25.11.2002	National basic fee paid
	25.11.2002	Designation fee(s) paid
	25.11.2002	Examination fee paid
Examination procedure	17.10.2001	Request for preliminary examination filed International Preliminary Examining Authority: EP
	25.11.2002	Examination requested [2003/06]
	19.01.2004	Despatch of a communication from the examining division (Time limit: M08)
	16.09.2004	Reply to a communication from the examining division
	19.01.2005	Despatch of a communication from the examining division (Time limit: M04)
	28.04.2005	Reply to a communication from the examining division
	28.06.2005	Despatch of a communication from the examining division (Time limit: M03)
	20.08.2005	Reply to a communication from the examining division
	30.09.2005	Despatch of a communication from the examining division (Time limit: M02)
	21.10.2005	Reply to a communication from the examining division
	21.11.2005	Despatch of a communication from the examining division (Time limit: M02)
	13.01.2006	Reply to a communication from the examining division
	23.03.2006	Communication of intention to grant the patent
	02.08.2006	Fee for grant paid
	02.08.2006	Fee for publishing/printing paid
Opposition(s)	21.06.2007	No opposition filed within time limit [2007/35]
Fees paid	Renewal fee
	02.05.2003	Renewal fee patent year 03
	03.05.2004	Renewal fee patent year 04
	02.05.2005	Renewal fee patent year 05
	02.05.2006	Renewal fee patent year 06
Opt-out from the exclusive Tooltip competence of the Unified Patent Court	See the Register of the Unified Patent Court for opt-out data
	Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition Tooltip	CY	20.09.2006
	FI	20.09.2006
	IT	20.09.2006
	TR	20.09.2006
	GR	21.12.2006
	PT	12.03.2007
	IE	25.04.2007
	LU	25.04.2007
	MC	30.04.2007
	[2009/42]
Former [2009/37]	CY	20.09.2006
	FI	20.09.2006
	IT	20.09.2006
	GR	21.12.2006
	PT	12.03.2007
	IE	25.04.2007
	LU	25.04.2007
	MC	30.04.2007
Former [2009/18]	FI	20.09.2006
	IT	20.09.2006
	GR	21.12.2006
	PT	12.03.2007
	IE	25.04.2007
	MC	30.04.2007
Former [2008/25]	FI	20.09.2006
	IT	20.09.2006
	GR	21.12.2006
	PT	12.03.2007
	IE	25.04.2007
Former [2008/19]	FI	20.09.2006
	IT	20.09.2006
	GR	21.12.2006
	PT	12.03.2007
Former [2007/35]	FI	20.09.2006
	IT	20.09.2006
	PT	12.03.2007
Former [2007/26]	FI	20.09.2006
	PT	12.03.2007
Former [2007/10]	FI	20.09.2006
Cited in	International search	[DA]WO9739721 (HARVARD COLLEGE [US], et al) [DA] * the whole document *;
		[DA]WO9921993 (ZENECA LTD [GB]) [DA] * the whole document *;
		[DA] - HODGE M R ET AL, "NF-AT-DRIVEN INTERLEUKIN-4 TRANSCRIPTION POTENTIATED BY NIP45", SCIENCE, AMERICAN ASSOCIATION FOR THE ADVANCEMENT OF SCIENCE,, US, (19961213), vol. 274, no. 5294, ISSN 0036-8075, page 1903, XP002045448 [DA] * the whole document * DOI: http://dx.doi.org/10.1126/science.274.5294.1903

The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.

Legal notice
Terms of use
24.2.25; 34p